Opko Biologics' P2P Acquisition

Opko Biologics raised a round of funding on August 29, 2013. Investors include OPKO Health.

Opko Biologics, formerly Prolor Biotech, is a clinical stage biopharmaceutical company applying unique technologies, including CTP technology, primarily to develop longer-acting versions of already ap…

Articles about Opko Biologics' P2P Acquisition: